Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01508104
Title Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Cincinnati
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Cincinnati Cincinnati Ohio 45267-0502 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field